Insider Transactions
| Date | Filer | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|
| Jul 27, 2021 |
Director, Chairman, President & CEO
|
Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,689 | -- | 9,043 |
| Jul 27, 2021 |
Director, Chairman, President & CEO
|
Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,689 | -- | 7,180 |
| Feb 25, 2021 |
Director, Chairman, President & CEO
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,291 | -- | 12,291 |
| Jul 27, 2020 |
Director, President & CEO
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,869 | -- | 14,869 |
| Jul 27, 2020 |
Director, President & CEO
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,992 | -- | 10,992 |
| Jan 30, 2020 |
Director
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 372 | -- | 1,381 |
| Jan 31, 2019 |
Director
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 535 | -- | 984 |
| Jan 31, 2018 |
Director
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 436 | -- | 437 |
| Jan 11, 2018 |
Director
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 09, 2019 |
Director
|
Form 4 | Open market or private purchase of non-derivative or derivative security | 1,354 | $376.32 | 1,354 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.